Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2018 1
2019 1
2020 2
2023 2

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Normal organ dosimetry for thyroid cancer patients treated with radioiodine as part of the multi-centre multi-national Horizon 2020 MEDIRAD project.
Taprogge J, Vergara-Gil A, Leek F, Abreu C, Vávrová L, Carnegie-Peake L, Schumann S, Eberlein U, Lassmann M, Schurrat T, Luster M, Verburg FA, Vallot D, Vija L, Courbon F, Newbold K, Bardiès M, Flux G. Taprogge J, et al. Among authors: vallot d. Eur J Nucl Med Mol Imaging. 2023 Sep;50(11):3225-3234. doi: 10.1007/s00259-023-06295-0. Epub 2023 Jun 10. Eur J Nucl Med Mol Imaging. 2023. PMID: 37300572 Free PMC article.
Setting up a quantitative SPECT imaging network for a European multi-centre dosimetry study of radioiodine treatment for thyroid cancer as part of the MEDIRAD project.
Taprogge J, Leek F, Schurrat T, Tran-Gia J, Vallot D, Bardiès M, Eberlein U, Lassmann M, Schlögl S, Vergara Gil A; MEDIRAD WP3 Investigator Team; Flux GD. Taprogge J, et al. Among authors: vallot d. EJNMMI Phys. 2020 Oct 8;7(1):61. doi: 10.1186/s40658-020-00332-9. EJNMMI Phys. 2020. PMID: 33030702 Free PMC article.
Fluorine-18-fluorocholine PET/CT parameters predictive for hematological toxicity to radium-223 therapy in castrate-resistant prostate cancer patients with bone metastases: a pilot study.
Vija Racaru L, Sinigaglia M, Kanoun S, Ben Bouallègue F, Tal I, Brillouet S, Bauriaud-Mallet M, Zerdoud S, Dierickx L, Vallot D, Caselles O, Gabiache E, Pascal P, Courbon F. Vija Racaru L, et al. Among authors: vallot d. Nucl Med Commun. 2018 Jul;39(7):672-679. doi: 10.1097/MNM.0000000000000850. Nucl Med Commun. 2018. PMID: 29790867 Free PMC article.
Clinical outcomes 1 year after empiric 131I therapy for hyperthyroid disorders: real life experience and predictive factors of functional response.
Vija Racaru L, Fontan C, Bauriaud-Mallet M, Brillouet S, Caselles O, Zerdoud S, Bastié D, Vallot D, Caron P, Bardiès M, Courbon F. Vija Racaru L, et al. Among authors: vallot d. Nucl Med Commun. 2017 Sep;38(9):756-763. doi: 10.1097/MNM.0000000000000705. Nucl Med Commun. 2017. PMID: 28719405 Clinical Trial.